Literature DB >> 14572860

In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations.

Ramesh Panchagnula1, Shradha Rungta, Pavankumar Sancheti, Shrutidevi Agrawal, Chaman Lal Kaul.   

Abstract

Rifampicin is one of the major first line anti-tuberculosis drugs used in the therapy of tuberculosis. In literature, there are conflicting reports regarding effect of food on the bioavailability of rifampicin. In vitro, effect of food on the bioavailability can be studied by simulating in vivo conditions in dissolution fluid hence, to understand the variable effect of food on rifampicin release, dissolution studies were done by simulating in vivo conditions after meal intake. In this study, we assessed the effect of hydrodynamic stress in presence of food and meal composition on two rifampicin containing fixed dose combination formulations by carrying out dissolution at different agitation rates (simulation of fasted and fed state) as well as in the presence of different percentage of oil (fatty food). Agitation intensity as well as presence of oil did not had any influence on rifampicin release from formulation A. This formulation had shown excellent release characteristics at all the conditions studied. Whereas, formulation B showed agitation rate dependent release and also release was affected in presence of oil. Hence, it is concluded that food may not have any effect on the release of rifampicin from the formulation and subsequently on its bioavailability if the formulation has excellent release profile (>85% release in 10 min). Further, effect of food on the rifampicin release was a function of dosage form characteristics such as disintegration time and dissolution rate, which will subsequently affect the release behavior of a formulation in presence of food.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572860     DOI: 10.1016/S0014-827X(03)00161-7

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  2 in total

1.  Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Authors:  Justin J Wilkins; Radojka M Savic; Mats O Karlsson; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

2.  Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs.

Authors:  Agibothu Kupparam Hemanth Kumar; Vedachalam Chandrasekaran; Angadi Kiran Kumar; M Kawaskar; J Lavanya; Soumya Swaminathan; Geetha Ramachandran
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.